Evaluating health-related quality of life and health resource utilization among Gabapentinoid users with substance use disorder in the US: Trends, co-prescriptions, and cost analysis.

Explor Res Clin Soc Pharm · 2025 · PMC12210304 · PMID 40599591

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

We also observed an increasing trend in gabapentinoid use from 2015 to 2021, with a notable surge between 2017 and 2018.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.